Sub-chronic inhalation of lead oxide nanoparticles revealed their broad distribution and tissue-specific subcellular localization in target organs
Jana Dumková,T. Smutná,Lucie Vrlíková,P. Le Coustumer,P. Le Coustumer,Z. Večeřa,Bohumil Dočekal,Pavel Mikuška,Lukáš Čapka,Petr Fictum,Aleš Hampl,Marcela Buchtová,Marcela Buchtová +12 more
TL;DR: In this article, the authors investigate lead oxide nanoparticle distribution through the body upon their entry into lungs and determine the microscopic and ultramicroscopic changes caused by the nanoparticles in primary and secondary target organs.
read more
Abstract: Lead is well known environmental pollutant, which can cause toxic effects in multiple organ systems. However, the influence of lead oxide nanoparticles, frequently emitted to the environment by high temperature technological processes, is still concealed. Therefore, we investigate lead oxide nanoparticle distribution through the body upon their entry into lungs and determine the microscopic and ultramicroscopic changes caused by the nanoparticles in primary and secondary target organs. Adult female mice (ICR strain) were continuously exposed to lead oxide nanoparticles (PbO-NPs) with an average concentration approximately 106 particles/cm3 for 6 weeks (24 h/day, 7 days/week). At the end of the exposure period, lung, brain, liver, kidney, spleen, and blood were collected for chemical, histological, immunohistochemical and electron microscopic analyses. Lead content was found to be the highest in the kidney and lungs, followed by the liver and spleen; the smallest content of lead was found in brain. Nanoparticles were located in all analysed tissues and their highest number was found in the lung and liver. Kidney, spleen and brain contained lower number of nanoparticles, being about the same in all three organs. Lungs of animals exposed to lead oxide nanoparticles exhibited hyperaemia, small areas of atelectasis, alveolar emphysema, focal acute catarrhal bronchiolitis and also haemostasis with presence of siderophages in some animals. Nanoparticles were located in phagosomes or formed clusters within cytoplasmic vesicles. In the liver, lead oxide nanoparticle exposure caused hepatic remodeling with enlargement and hydropic degeneration of hepatocytes, centrilobular hypertrophy of hepatocytes with karyomegaly, areas of hepatic necrosis, occasional periportal inflammation, and extensive accumulation of lipid droplets. Nanoparticles were accumulated within mitochondria and peroxisomes forming aggregates enveloped by an electron-dense mitochondrial matrix. Only in some kidney samples, we observed areas of inflammatory infiltrates around renal corpuscles, tubules or vessels in the cortex. Lead oxide nanoparticles were dispersed in the cytoplasm, but not within cell organelles. There were no significant morphological changes in the spleen as a secondary target organ. Thus, pathological changes correlated with the amount of nanoparticles found in cells rather than with the concentration of lead in a given organ. Sub-chronic exposure to lead oxide nanoparticles has profound negative effects at both cellular and tissue levels. Notably, the fate and arrangement of lead oxide nanoparticles were dependent on the type of organs.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale
Sabina Halappanavar,Sybille van den Brule,Penny Nymark,Laurent Gaté,Carole Seidel,Sarah Valentino,Vadim Zhernovkov,Pernille Høgh Danielsen,Andrea De Vizcaya,Andrea De Vizcaya,Henrik Wolff,Tobias Stöger,Andrey Boyadziev,Sarah S. Poulsen,Jorid B. Sørli,Ulla Vogel +15 more
TL;DR: A brief overview of the AOP framework and its application to nanotoxicology, tools for developing AOPs and the role of toxicogenomics are detailed, and various AOP's of relevance to inhalation toxicity of nanomaterials that are currently under various stages of development are summarized.
Cadmium and Lead Exposure, Nephrotoxicity, and Mortality.
Soisungwan Satarug,Glenda C. Gobe,Glenda C. Gobe,David A. Vesey,David A. Vesey,Kenneth R. Phelps +5 more
TL;DR: Findings indicate that the current tolerable intake of Cd and the conventional urinary Cd threshold limit do not provide adequate health protection, and actions to minimize environmental exposure to these toxic metals are imperative.
157
The Toxicity Of Metallic Nanoparticles On Liver: The Subcellular Damages, Mechanisms, And Outcomes.
TL;DR: This review focuses on the recent researches on the liver toxicity of MNP and its mechanisms at cellular and subcellular levels to provide a scientific basis for the subsequent hepatotoxicity studies of MNPs.
Toxicological status of nanoparticles: What we know and what we don't know.
TL;DR: This review summarizes the knowledge on nanoparticles, including their various applications, routes of exposure, their potential toxicity and risks to human health.
139
Multiple organ injury in male C57BL/6J mice exposed to ambient particulate matter in a real-ambient PM exposure system in Shijiazhuang, China.
Daochuan Li,Rong Zhang,Lianhua Cui,Chen Chu,Haiyan Zhang,Hao Sun,Jing Luo,Lixiao Zhou,Liping Chen,Jian Cui,Shen Chen,Bi-Xian Mai,She-Jun Chen,Jian Zhen Yu,Zongwei Cai,Jianqing Zhang,Yousheng Jiang,Michael Aschner,Rui Chen,Yuxin Zheng,Wen Chen +20 more
TL;DR: The findings revealed the severity, sensitivity, and reversibility of multi-organ injury in response to a real-ambient PM exposure and suggested the PM2.5-induced inflammatory response, the chemical components-induced cytotoxicity, genetic damage, and oxidative stress might be implicated in the impairment of multiple murine organs.
134
References
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
TL;DR: The present “gold standard” management of NASH is modest weight reduction, particularly correction of central obesity achieved by combining dietary measures with increased physical activity, which improves insulin resistance and reverses steatosis, hepatocellular injury, inflammation, and fibrosis.
2.5K
Kinetic analysis of lead metabolism in healthy humans.
TL;DR: The steady state kinetics of lead metabolism were studied in five healthy men with stable isotope tracers and the data suggest a three compartmental model for lead metabolism.
Low-level lead exposure and children's IQ : a meta-analysis and search for a threshold
TL;DR: A highly significant association was found between lead exposure and children's IQ and the effect was robust to inclusion or exclusion of the strongest individual studies and to relaxing the age requirements of the meta-analysis.
699
•Journal Article
Non alcoholic fatty liver disease and metabolic syndrome.
TL;DR: Current knowledge on the epidemiology, pathophysiology and diagnosis of both NAFLD and metabolic syndrome and the findings that strongly support the association of nonalcoholic fatty liver disease as a possible component in the cluster of metabolic syndrome are summarized.
582
Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles
Jiangxue Wang,Ying Liu,Fang Jiao,Fang Lao,Wei Li,Yiqun Gu,Yufeng Li,Cuicui Ge,Guoqiang Zhou,Bai Li,Yuliang Zhao,Zhifang Chai,Chunying Chen +12 more
TL;DR: Rutile ultrafine-TiO(2) particles are expected to have a little lower risk potential for producing adverse effects on central nervous system, although understanding the mechanisms requires further investigation, the present results suggest that the authors should pay attention to potential risk of occupational exposure for large-scaled production of TiO( 2) nanoparticles.
451